UK Ministers urge pharma price cuts
As the Marketletter was going to press, UK Chancellor of the ExchequerGordon Brown and International Development Secretary Clare Short were due to ask pharmaceutical companies to supply developing nations with treatments for HIV/AIDS, tuberculosis and malaria at deeply discounted prices.
Ahead of the announcement, the Guardian newspaper reported Mr Brown as saying: "there is an expectation that the industry should do more. It's time for the pharmaceutical companies to do more. The evidence is that the drugs companies can do more."
Mr Brown was also expected to announce that the UK government would be providing L75 million ($106.6 million) to the international drugs fund proposed by United Nations Secretary General Kofi Annan (Marketletters passim).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze